Owen N. Witte, Director at Allogene Therapeutics, Inc. (ALLO), sold 15,000 shares at $16.50 ($251K) on 2022-08-11, disclosed to the SEC on 2022-08-15.
Open-market sale of $251k ALLO by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $16.50 | 10,000 | $165K | 65.7% |
| 2 | $17.25 | 5,000 | $86K | 34.3% |
| Total | $16.75 avg | 15,000 | $251K | 100% |
| Filing → |
| ALLO | SELL | 2021-08-23 | $351K | — | Filing → |
| ALLO | SELL | 2021-06-11 | $499K | — | Filing → |
| ALLO | BUY | 2018-10-17 | $270K | — | Filing → |